Hoffmann-la Roche Drug Patent Portfolio

Hoffmann-la Roche's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hoffmann-la Roche News

Risdiplam has lost its patent protection. What are the next steps? - The Hindu

23 Nov, 2025

Delhi High Court's Decision in the Case of F. Hoffmann-La Roche Ag & Anr. vs. Natco Pharma

03 Nov, 2025

Roche Takes Legal Action in Supreme Court Following Delhi High Court Ruling Permitting Natco To ... - The Law Advice

14 Oct, 2025

Delhi High Court Permits Natco to Market Spinal Muscular Atrophy Medication, Denies Roche's Appeal - Live Law

10 Oct, 2025

See More